
Virpax Pharmaceuticals
Pharmaceuticals, 1055 Westlakes Dr, Berwyn, Pennsylvania, 19312, United States, 1-10 Employees
Who is VIRPAX PHARMACEUTICALS
Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers lo...
Read More

-
Headquarters: 1055 Westlakes Dr, Berwyn, Pennsylvania, 19312, United States
-
Date Founded: 2017
-
Employees: 1-10
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
-
CEO: Anthony Mack
Industry: Pharmaceuticals
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from VIRPAX PHARMACEUTICALS
Virpax Pharmaceuticals Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Virpax Pharmaceuticals
Answer: Virpax Pharmaceuticals's headquarters are located at 1055 Westlakes Dr, Berwyn, Pennsylvania, 19312, United States
Answer: Virpax Pharmaceuticals's official website is https://virpaxpharma.com
Answer: Virpax Pharmaceuticals's revenue is $1 Million to $5 Million
Answer: Virpax Pharmaceuticals's SIC: 2834
Answer: Virpax Pharmaceuticals has 1-10 employees
Answer: Virpax Pharmaceuticals is in Pharmaceuticals
Answer: Virpax Pharmaceuticals contact info: Phone number: Website: https://virpaxpharma.com
Answer: Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our dedication to addressing drug-resistant epilepsy and rare diseases. With a focus on optimizing non-addictive medications, our drug delivery platforms target unmet global needs in markets such as Post Operative Pain, Severe Pain, Post Cancer Pain, and Rare Pediatric Epilepsy, including orphan diseases like Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome. Virpax is at the forefront of providing differentiated solutions for these diverse healthcare challenges.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface

Sign in to CIENCE GO Data to uncover contact details
Free credits every month